Details for New Drug Application (NDA): 091382
✉ Email this page to a colleague
The generic ingredient in LIOTHYRONINE SODIUM is liothyronine sodium. There are four drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.
Summary for 091382
Tradename: | LIOTHYRONINE SODIUM |
Applicant: | Sun Pharm |
Ingredient: | liothyronine sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 091382
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LIOTHYRONINE SODIUM | liothyronine sodium | TABLET;ORAL | 091382 | ANDA | Sun Pharmaceutical Industries, Inc. | 62756-589 | 62756-589-01 | 90 TABLET in 1 BOTTLE (62756-589-01) |
LIOTHYRONINE SODIUM | liothyronine sodium | TABLET;ORAL | 091382 | ANDA | Sun Pharmaceutical Industries, Inc. | 62756-589 | 62756-589-08 | 100 TABLET in 1 BOTTLE (62756-589-08) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 0.005MG BASE | ||||
Approval Date: | Apr 20, 2016 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 0.025MG BASE | ||||
Approval Date: | Apr 20, 2016 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 0.05MG BASE | ||||
Approval Date: | Apr 20, 2016 | TE: | AB | RLD: | No |
Complete Access Available with Subscription